| 151 |
Design and preparation of a fluorescent molecularly imprinted membrane for the selective detection of pepsin enzyme as a biomarker for gastroesophageal reflux disease |
|
2024 |
| 152 |
Design and preparation of a fluorescent molecularly imprinted membrane for the selective detection of pepsin enzyme as a biomarker for gastroesophageal reflux disease. |
Department of Pharmaceutical Analytical Chemistry |
2024 |
| 153 |
Design and synthesis new dihydropyrimidine derivatives with cytotoxic effect as dual EGFR/VEGFR-2 inhibitors |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 154 |
Design and synthesis new indole-based aromatase/iNOS inhibitors with apoptotic antiproliferative activity |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 155 |
Design and synthesis of new 1, 2, 4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 156 |
Design and synthesis of New dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 157 |
Design and synthesis of novel quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 158 |
Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 159 |
Design, synthesis, and antiproliferative activity of new 1, 2, 3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAF V600E inhibitors |
Department of Pharmaceutical Organic Chemistry |
2024 |
| 160 |
Design, synthesis, and antiproliferative activity of new indole/1,2,4-triazole/chalcone hybrids as EGFR and/or c-MET inhibitors |
Department of Pharmaceutical Organic Chemistry |
2024 |
Do you have any questions? (088) 2080369 - 2345622 Pharmacy_QAAU@pharm.aun.edu.eg
